Loading clinical trials...
Loading clinical trials...
Aciclovir for HSV-2 Meningitis: A Double-blind Randomised Controlled Trial (AMEN)
Conditions
Interventions
Acyclovir 50 MG/ML
Placebo
Start Date
June 1, 2026
Primary Completion Date
June 1, 2028
Completion Date
June 1, 2029
Last Updated
October 1, 2025
NCT06922474
NCT04710030
NCT03282916
NCT01681420
Lead Sponsor
Jacob Bodilsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions